Ullet index:DAIICHI SANKYO COMPANY, LIMITED:4568

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index DAIICHI SANKYO COMPANY, LIMITED Go to web site 4568 Medicals 東証プライム March 1, 2000 2005.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

DAIICHI SANKYO COMPANY, LIMITED mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 1,688,174
plusup
1,445,854
plusup
1,350,872
plusup
1,272,053
plusdown
1,305,810
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp 200,732
plusup
109,188
plusup
66,973
plusdown
75,956
plusdown
129,075
plus
Operating Cash Flow(OFC)Help 590,036
plusup
114,514
plusdown
139,226
plusdown
192,207
plusdown
196,601
plus
Free Cash Flow(FCF)Help 307,400
plusup
-143,268
plusdown
351,565
plusup
152,961
plusdown
278,274
plus
OFC - Net IncomeHelp 74
plusup
72
plusup
66
plusup
65
plusdown
65
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp 117.45%
plusup
21.46%
plusdown
22.54%
plusdown
31.06%
plusup
25.60%
plus
Current Assets / Amount of SalesHelp 31.37%
plusdown
41.75%
plusdown
59.13%
plusdown
64.28%
plusdown
78.24%
plus
Free Cash Revenue RatioHelp 19.19%
plusup
-11.21%
plusdown
33.65%
plusup
15.89%
plusdown
28.34%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

DAIICHI SANKYO COMPANY, LIMITED

Company where related level is highHelp

StemRIM Inc.
MORISHITA JINTAN CO.,LTD.
EIKEN CHEMICAL CO.,LTD.
KISSEI PHARMACEUTICAL CO.,LTD.
RaQualia Pharma Inc.
MUROMACHI CHEMICALS INC.
Perseus Proteomics Inc.
NIPPON CHEMIPHAR CO.,LTD.
Fuso Pharmaceutical Industries, Ltd.
Chiome Bioscience Inc.